Pfizer Sends Shockwaves Throughout Vaccine Industry with Announcement About Omicron Variant

This is extraordinarily suspect.

The Omicron variant was isolated less than a month ago in Botswana, but Pfizer claims its existing booster provides the missing protection that the "vaccines" lack. This is an extraordinarily suspect claim that requires further investigation.

"Preliminary lab studies show two doses of the Pfizer/BioNTech vaccine may not provide sufficient protection against the Omicron coronavirus variant, but three doses are able to neutralize it, the companies said in a news release on Wednesday," CNN uncritically reported.

"Samples from people who had two doses of the Covid-19 vaccine saw, on average, a more than 25-fold reduction in neutralization ability against the Omicron variant than the earlier virus, 'indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant,' CNN cited the companies as saying.

This is quite the admission that the prior "vaccines" do almost nothing to stop the spread of the Omicron variant.

This is what Pfizer is claiming the "preliminary" data show, according to its release.